comprehensive -WSS

comprehensive

author：knowledge 2025-08-12 09:12:42 - browse：37557

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： STAT Virtual Event: How to Increase Diversity in Clinical Trials

WSS

Would Medicare drug price negotiations stall in a shutdown?

#NeedHerScience: shining a light on gender disparities in medicine

The battle over the Brookhaven Landfill on Long Island

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

In areas with more Black doctors, Black people live longer

Kaiser Permanente unions announce official strike date

focus

comprehensive

hotspot

Sports medicine is finally prioritizing gender equality

CDC concerned about possible undetected monkeypox spread in U.K.

How one medical school became remarkably diverse

Would Medicare drug price negotiations stall in a shutdown?

In Memoriam: Notable people who died in 2023

STAT's guide to the next generation of CAR

Bright Health sells Medicare Advantage business to Molina

Ask STAT: What do you want to know about ChatGPT in medicine?

Psychedelics group wrestles with new pharma identity

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

focus

Donald Trump's relentless attacks on special counsel Jack Smith

What would happen to your eyes if you looked at the solar eclipse?

Covid vaccines: Private market messier than government rollout

After a drawn out lobbying fight, ARPA

CDC concerned about possible undetected monkeypox spread in U.K.

FDA advisers vote against ALS treatment from BrainStorm

focus

focus

hotspot

entertainment